Corcept Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 12.43 M | $1.08 B | 2.31% | 11.90% |
| INGALLS & SNYDER LLC | 08/14/2026 | 7.93 M | $689.91 M | 4.28% | 7.60% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 5.26 M | $457.50 M | -7.41% | 5.04% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 5.04 M | $438.63 M | 4.65% | 4.83% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.17 M | $362.80 M | 2.34% | 4.00% |
| PARALLEL ADVISORS, LLC | 08/05/2026 | 3.96 M | $344.51 M | -0.38% | 3.79% |
| FMR LLC | 08/13/2026 | 3.34 M | $290.21 M | 4.62% | 3.20% |
| STATE STREET CORP | 08/07/2026 | 3.28 M | $285.15 M | 2.45% | 3.14% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 2.58 M | $224.55 M | 535.78% | 2.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.53 M | $220.21 M | -6.68% | 2.42% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 1.83 M | $159.08 M | -15.82% | 1.75% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.50 M | $130.43 M | 0.00% | 1.44% |
| UBS GROUP AG | 08/13/2026 | 1.38 M | $119.79 M | 1.03% | 1.32% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.32 M | $114.68 M | -15.09% | 1.26% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.16 M | $100.65 M | 3.36% | 1.11% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.16 M | $100.65 M | 100.00% | 1.11% |
| MORGAN STANLEY | 08/13/2026 | 1.14 M | $98.91 M | 11.65% | 1.09% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 883.00 K | $76.78 M | -25.25% | 0.85% |
| CERITY PARTNERS LLC | 08/14/2026 | 797.12 K | $69.31 M | 8.94% | 0.76% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 771.03 K | $67.04 M | -21.78% | 0.74% |
| NORTHERN TRUST CORP | 08/13/2026 | 753.80 K | $65.54 M | 17.20% | 0.72% |
| EMERALD ADVISERS, LLC | 08/05/2026 | 748.33 K | $65.07 M | 264.05% | 0.72% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 08/12/2026 | 710.11 K | $61.74 M | 100.00% | 0.68% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2026 | 695.53 K | $60.48 M | 100.00% | 0.67% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 614.08 K | $53.39 M | 4.03% | 0.59% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 610.08 K | $53.05 M | -35.50% | 0.58% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 568.52 K | $49.43 M | -21.67% | 0.54% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 565.67 K | $49.18 M | 4.03% | 0.54% |
| INVESCO LTD. | 08/14/2026 | 523.67 K | $45.53 M | -16.66% | 0.50% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 08/13/2026 | 523.19 K | $46.29 M | 143.83% | 0.50% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 520.00 K | $45.21 M | 220.99% | 0.50% |
| NORGES BANK | 08/12/2026 | 487.06 K | $42.35 M | 100.00% | 0.47% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 08/05/2026 | 464.90 K | $40.42 M | 158.84% | 0.45% |
| PRINCIPAL FINANCIAL GROUP INC | 08/04/2026 | 459.74 K | $39.97 M | 0.99% | 0.44% |
| BOSTON TRUST WALDEN CORP | 07/24/2026 | 440.26 K | $38.28 M | -4.83% | 0.42% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 398.39 K | $34.64 M | 696.77% | 0.38% |
| NUVEEN, LLC | 08/11/2026 | 388.08 K | $33.74 M | 102.23% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 355.80 K | $30.94 M | 7.79% | 0.34% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 335.50 K | $29.17 M | 34.20% | 0.32% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 328.57 K | $28.57 M | 194.05% | 0.31% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 08/13/2026 | 328.22 K | $28.54 M | -1.99% | 0.31% |
| FAS WEALTH PARTNERS, INC. | 07/29/2026 | 324.88 K | $28.25 M | 0.78% | 0.31% |
| CITADEL ADVISORS LLC | 08/14/2026 | 257.70 K | $22.41 M | 23.48% | 0.25% |
| JPMORGAN CHASE & CO | 08/12/2026 | 253.18 K | $22.65 M | 25.99% | 0.24% |
| LEGAL & GENERAL GROUP PLC | 08/14/2026 | 218.08 K | $18.96 M | -0.73% | 0.21% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 212.16 K | $18.45 M | 0.04% | 0.20% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 212.03 K | $18.44 M | -30.53% | 0.20% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 211.02 K | $18.35 M | 19.12% | 0.20% |
| DIADEMA PARTNERS LP | 08/14/2026 | 206.30 K | $17.94 M | 30.16% | 0.20% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 202.74 K | $17.63 M | -6.77% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Corcept Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 596 institutional investors and hedge funds held shares of Corcept Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 12.43 M
INGALLS & SNYDER LLC: 7.93 M
RENAISSANCE TECHNOLOGIES LLC: 5.26 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 5.04 M
VANGUARD CAPITAL MANAGEMENT LLC: 4.17 M
Parallel Advisors, LLC: 3.96 M
79.84% of Corcept Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 121.10 M shares in the last 24 months. This purchase volume represents approximately $4.12 B in transactions.